Europe In-Vitro Diagnostics Market is predicted to reach USD 18.67 Billion by 2030

According to the study by Next Move Strategy Consulting, the Europe In-Vitro Diagnostics Market size is predicted to reach USD 18.67 billion, at a CAGR of 2.9% by 2030.

Request a FREE Sample: https://www.nextmsc.com/europe-in-vitro-diagnostics-market/request-sample

Europe's aging demographic profile amplifies the need for immunodiagnostic innovations, as age-related ailments become more prevalent.

The strategic investments in research and development, alongside collaborative efforts within the industry, propel innovation and drive the development of cutting-edge diagnostic tools.

The substantial healthcare expenditure is significant in propelling the growth of the in-vitro diagnostics market in this region.

The promising players operating in the Europe in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.